Concepedia

Michela Piezzo

MP

7

Publications

366

Citations

7

H-Index

2017

Active since

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

University of Naples Federico II

Istituti di Ricovero e Cura a Carattere Scientifico

Michela Piezzo is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in tumor immunity, breast cancer, and immunology.

ORCID

Top concepts

Publications per year

2017–2024

7

Publications

7

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

Gerardo Botti, Francesca Collina, Giosuè Scognamiglio et al. · International Journal of Molecular Sciences · 2017 · 112 citations · Full text

, , +20

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models

Stefania Cocco, Alessandra Leone, Maria Serena Roca et al. · Journal of Translational Medicine · 2022 · 109 citations · Full text

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

Roberta Caputo, Giuseppe Buono, Michela Piezzo et al. · Frontiers in Oncology · 2024 · 61 citations · Full text

Clinical trials and drug cost savings for Italian health service

Francesca D’Ambrosio, Gianfranco De Feo, Gerardo Botti et al. · BMC Health Services Research · 2020 · 32 citations · Full text

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Marina Elena Cazzaniga, Mario Airoldi, Valentina Arcangeli et al. · The Breast · 2017 · 23 citations · Full text

Rows per page

1–5 of 7